Yann Le Baleur - Concepedia

Author

Yann Le Baleur

Assistance Publique – Hôpitaux de Paris

Also Known As

Y Le Baleur, Y Le baleur, Y. Le Baleur, Yann L E Baleur, Yann L. Baleur, Yann Le Baleur, Yann Le baleur, Yann le baleur

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Assistance Publique – Hôpitaux de Paris Université Paris-Est Créteil Inserm Hôpitaux Universitaires Henri-Mondor Hôpital Cochin

About

Yann Le Baleur is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, gastroenterology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	471
2	Gastroenterology	8	8	325
3	Pathology	5	5	328
4	Immunology	4	4	179
5	Microbiology	1	1	131

Yann Le Baleur

Publications

936

Citations

H-Index

Page 1

	Year	Citations
Outcome of Patients With Type 1 or 2 Autoimmune Pancreatitis Frédérique Maire, Yann Le Baleur, Vinciane Rebours, The American Journal of Gastroenterology	2010	186
Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Iradj Sobhani, Aurélien Amiot, Yann Le Baleur, Therapeutic Advances in Gastroenterology ProbioticBacteria-related DiseaseColon CarcinogenesisDysbiosisMicrobial Disease	2013	131
A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the “GRAPHE” registry) Sami Haddara, Jérémie Jacques, Stéphane Lecleire, Endoscopy	2016	107
Mucinous Cystic Neoplasms of the Pancreas: Definition of Preoperative Imaging Criteria for High-Risk Lesions Yann Le Baleur, Anne Couvelard, Marie‐Pierre Vullierme, Pancreatology Preoperative Imaging CriteriaSurgical OncologyPancreatic CancerPancreatic Fluid CollectionSurgical Pathology	2011	77
Immunoglobulin G4 Immunostaining of Gastric, Duodenal, or Colonic Biopsies Is Not Helpful for the Diagnosis of Autoimmune Pancreatitis Vinciane Rebours, Yann Le Baleur, Dominique Cazals‐Hatem, Clinical Gastroenterology and Hepatology Autoimmune DiseaseMedicineImmunologyGastroenterologyPathology	2011	65
Complete endoscopic sphincterotomy with vs. without large-balloon dilation for the removal of large bile duct stones: randomized multicenter study David Karsenti, Emmanuel Coron, Geoffroy Vanbiervliet, Endoscopy	2017	56
Therapeutic drug monitoring is predictive of loss of response after de-escalation of infliximab therapy in patients with inflammatory bowel disease in clinical remission Aurélien Amiot, Anne Hulin, Mehdi Belhassan, Clinics and Research in Hepatology and Gastroenterology InflammationTherapeutic Drug MonitoringAnti-inflammatoryClinical RemissionImmunology	2015	42
Endoscopic transgastric versus surgical necrosectomy in infected pancreatic necrosis V. Tan, Antoine Charachon, Thomas Lescot, Clinics and Research in Hepatology and Gastroenterology Pancreatic Fluid CollectionSurgical PathologyGastroenterologyPancreatic SurgeryInfected Pancreatic Necrosis	2014	38
Infliximab as a bridge to remission maintained by antimetabolite therapy in Crohn's disease: A retrospective study Armelle Chauvin, Aurélie Le Thuaut, Mehdi Belhassan, Digestive and Liver Disease InflammationChronic Inflammatory DiseasesAntimetabolite TherapyRetrospective StudyAnti-inflammatory	2014	37
Rituximab and chlorambucil versus rituximab alone in gastric mucosa-associated lymphoid tissue lymphoma according to t(11;18) status: a monocentric non-randomized observational study Michaël Lévy, Christiane Copie‐Bergman, Aurélien Amiot, Leukemia & lymphoma/Leukemia and lymphoma Lymphoid NeoplasiaTherapeutic Drug MonitoringForty-nine PatientsMedicineMetronomic Therapy	2012	35

Page 1